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ABSTRACT 
 
Previous research within the Curran group has demonstrated that ferrocene may be used as an 
organometallic constraint to induce the formation of α-helices in short peptides which traditionally 
possess undefined conformations. Through strategic placement of lysine residues at the i and i+3 
positions within the peptide, such a constraint was accomplished via the crosslinking of the lysine side 
chains to ferrocene dicarboxylic acid chloride in solution phase synthesis. The aim of this work was to 
develop a method for solid phase peptide synthesis (SPPS) for the synthesis of these ferrocene-
constrained helices. In particular, we seek to develop a method in which the nascent peptide can be 
cyclized while it is still anchored to the resin. For the synthesis, Fmoc-protected amino acids were utilized 
to afford the pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2. For the synthesis, Fmoc-protected 
amino acids and Aloc side chain protecting groups were utilized due to the mild conditions under which 
they are removed. This allowed the use of a Rink Amide AM resin, which is cleaved under acidic 
conditions. In this study it was found that on resin Pd
0
 catalyzed Aloc removal required very specific 
conditions and work up for efficient deprotection. Additionally, Fmoc-protected amino acids were utilized 
in an analogous manner to afford the pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2
.
 The Z-protected 
pentapeptide was then removed from the resin, hydrogenated using Pd on C and subsequently cyclized 
with 1,1’-ferrocenedicarboxylix acid chloride. Results from on-resin cyclization indicate that a new 
approach must be developed in order to accomplish on-resin cyclization. Future work includes the use of 
different resins, different protecting groups, and different removal conditions for optimization. In solution 
phase, the ferrocene coupling, the data indicates that a peptide dimer with a single ferrocene was formed 
due to incomplete Z protecting group removal. Future work in solution phase includes hydrogenation and 
cyclization optimization. 
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INTRODUCTION 
1.1 Protein Chemistry 
Within the body, proteins are responsible for a large number of the reactions essential to life. When 
describing the particular conformation of a protein, scientists describe protein structure in terms of four 
levels of organization: primary, secondary, tertiary, and quaternary. The primary structure of a protein is 
simply the linear arrangement of amino acids in a protein. The next level of organization is the secondary 
structure, which describes areas of coiling or folding which are formed via hydrogen within the protein 
backbone. The tertiary structure is the full three dimensional structure of a given protein. Finally, if 
multiple polypeptides make up a given protein complex, the protein is said to have a quaternary structure 
which describes the overall shape of the associated subunits.  
1.2 Alpha-Helices 
Among this hierarchy which describes the organization of a protein, secondary structures, in particular, 
are known to play a key role in many important biological activities of proteins. The most common of 
these structures, the α-helix, is adopted by 30% of all amino acids in proteins1. The α-helix is a structural 
motif involved in an array of vital functions such as protein-DNA interactions
2
, protein-protein 
interactions
3
, and membrane-bound receptors
4
. In the ideal α-helix hydrogen bonds form between amide 
protons and carbonyl groups of amino acids at the i and i+4 positions
5
 (see Figure 1.1). 
 
Figure 1.1: An α-helix with (a) Cα labeled, (b) peptide backbone labeled, (c) full structure and hydrogen bonds 
shown
6
. 
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In this particular conformation there are 3.6 amino acids per complete turn with Cα-N bond angles (Φ) of -
64 ± 7º and Cα-Cβ bond angles (ψ) of -41 ± 7º.
7
  
Due to the biological prevalence of α-helices, it is crucial that researchers have accessible model systems 
in order to further probe the intricacies of helix formation and its bioactivity. One of the largest 
complications of this need arises from the energetic difficulty which short peptide strands face in forming 
well-defined conformations due to their inherent flexibility
8
. Currently researchers have devised several 
reasonably successful methods to induce well defined helices using various conformational 
constraints
9,10,11
 which can be mainly categorized into three major categories: template, covalent and 
metal systems. 
1.3 Alpha-Helix Prediction 
Although researchers have several synthetic methods by which to nucleate alpha-helices, several 
statistical models can help predict whether a given peptide will form an alpha-helix. Previous analysis has 
shown that certain amino acids exhibit higher frequencies for different secondary structures. In particular, 
methionine, alanine, leucine, lysine, and uncharged glutamate have particularly high propensities to form 
alpha-helices
12
. Since the 1960s, researchers have also developed several computational methods to better 
predict alpha-helix formation, each of which has a varying degree of accuracy depending on the system 
being analyzed. The Chou-Fasman method relies heavily on the frequency of appearance of each amino 
acid in alpha-helices and has been shown to be roughly 50-60% accurate at predicting secondary 
structures
13
. A similar method developed by Garnier, Osguthorpe, and Robson (GOR) uses a similar 
method that not only takes into account the probability of each amino acid adopting a particular secondary 
structure but also the contributions of each amino acid’s neighbors a priori to comparison with proteins of 
known structure
14
.
 
Due to this difference, the GOR method is more sensitive and more accurate (around 
65%) than the Chou-Fasman method. 
A separate computational approach to predicting secondary structures is to analyze the sequences of 
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proteins with known structures and compare them to the desired system. Neural network methods 
machines use this approach by grouping amino acid sequences into sets to identify common sequence 
motifs of various secondary structures. Similarly based support vector machines use an analogous 
processing algorithm to achieve the same goal. These methods are typically greater than 70% accurate
13
. 
In more recent history, many of these prediction systems have been optimized and modified to include a 
number of other factors which have also been found to affect secondary structure formation
14
, including 
solvent systems, accessible residue surface area
16
, and protein structural class
17
. 
1.4 The Template Approach 
In template systems, the constraint is placed at one end of the peptide chain, which then serves to nucleate 
the formation of an α-helix. Typically, templates consist of semi-flexible cyclic systems containing 
multiple carbonyl groups which can participate in hydrogen bonds with the amide protons of the peptide 
backbone or within their cyclic framework
9
. Using this approach, several laboratories have been relatively 
successful at synthesizing a number of compounds which tend to adopt α-helical structures.18,19,20 (See 
Figure 1.2).  
 
   
 
 
Figure 1.2: Various templates for α-helix nucleation (a) Bisproline-based template developed by Gani, (b) Kemp & 
Curran’s bisproline-based template, (c) 4-oxo-hexahydroindole-3,6-dicarboxylic acid helix cap developed by 
Bartlett & Hutton, (d) Line angle representation of template mechanism of α-helix nucleation.7 
 
 
c b a 
d 
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Templates may also be successfully constructed by replacing the hydrogen bond promoting carbonyl 
group with sterically hindered covalent systems
21
 (See Figure 1.3).   
       
Figure 1.3: Satterwat’s hydrazone based hydrogen bond mimic, L = Leu, A = Ala, J = CH2, Z = CH2.
7 
While the template systems have been shown to successfully induce helix formation, these α-helices tend 
to form less than 50% in aqueous solution or were found to be highly length dependent with decreasing 
helicity as the peptide strand lengthened
10
. 
1.5 Covalent Constrained Systems 
In an alternative system, a covalent constraint is introduced by crosslinking amino acids placed at specific 
locations within the peptide. There are a variety of available methods for such systems which vary in both 
the positioning of the linkers and the crosslinking reaction type. Successful techniques include constraint 
via salt bridges
22
, lactam formation
23,24
, disulfide bonds
25
, thioether formation
26
,
 
amine formation
27
, carbon-
carbon bond formation (via ring olefin closing metathesis (RCM) reaction)
28
 and triazole formation via 
“click” type reactions29,30.  
In a relatively simple approach using salt bridges, α-helix formation is promoted by placing oppositely 
charged amino acids, such as glutamic acid and lysine at the i and i+4 positions which form ion pairs at 
desired positions, enhancing helix nucleation.
22
 Via a condensation reaction a lactam  may also be formed 
to induce helix formation
23,24
.
 
Additionally, this natural peptide based method has been accomplished by 
crosslinking two glutamine residues at the i and i+7 position
31
 (see Figure 1.4). 
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Figure 1.4: (a) Cartoon depicting Glu-Lys salt bridges in stabilized α-helix accomplished by Baldwin22, (b) Glu-Lys 
lactam-based constraint system developed by Fairlie, (c) Glutamine based lactam constraint system developed by 
Phelan.
7 
 
Disulfide bridges, a common structure found in proteins, are also used to form helices from short peptide 
strands. This process is accomplished by crosslinking modified amino acids at the i and i+7 positions of 
opposite stereochemistry
25
 via oxidation (see Figure 1.5). 
 
Figure 1.5: Shultz’s α-helix nucleation disulfide constraint25 
Similarly, two modified amino acids may be joined using bridging units of different lengths to aid in helix 
nucleation depending on the length of the desired cross linking.  By using semi-rigid organic compounds 
as bridging units, this method has been applied to systems with modified amino acids at the i and i+7, and 
i and i+11 positions
26,27
 (see Figure 1.6). 
 
 
 
 
c b a 
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Figure 1.6: Examples of spacer units utilized for α-helix formation, (a) 4-(aminomethyl)phenylacetic acid used by 
Taylor, (b) 3,3’-ethyne-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonicacid} used as a rigid crosslinker by 
Wooley.
7 
 
Ring closing metathesis (RCM) has also been applied to the formation of α-helices. In the most successful 
of these systems modified amino acids with terminal olefins at the i and i+7 positions with 10 total 
methylene spacing groups are crosslinked using Grubbs catalyst
28
 (see Figure 1.7). 
  
 
 
 
Figure 1.7: Various stapled peptides with different linker lengths and amino acid positions. R and S represent the 
stereochemistry of the adjacent amino acid position. The number in parentheses corresponds to the linker length.
28 
 
More recently, with the discovery of “click” type reactions29, on resin crosscoupling has been achieved 
using copper catalysts. “Click” mediated systems utilize modified amino acids at the i and i+3 positions 
one of which contains an azide and the other which contains an alkyne
30,31
 (see Figure 1.8). 
 
 
Figure 1.8: Dawson’s Triazole based tethering system formed through copper-assisted azide-alkyne cycloaddition 
(CuAAC).
31
 
Despite the success of many covalent systems, such methodologies often require non-native amino acids 
b a 
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such as αα-disubstituted amino acids and dehydroaminoacids. Additionally, a number of these reactions 
are run with harsh conditions, or expensive cross-coupling reagents such as Pd or Ni based catalysts. 
1.6 Metal Constrained Systems 
In the metal-ligand mediated system, metal coordinating amino acids such as histidine and cysteine 
placed within the peptide chain during synthesis are subsequently coordinated with the desired metal, 
constraining the peptide in such a way to induce formation of an α-helix. Metal constrained systems have 
been synthesized using a number of modified and native amino acids as well as a range of metals such as 
Pd
2+
, Co
2+
, Cu
2+
, Rh, and Cd
2+
 
33-36
 (see Figure 1.9).   
                                                           
Figure 1.9: (a) Simplified cartoon depiction of metal constrained α-helix, (b) Pd constrained system developed by 
Fairlie.
7 
 
Although the chemistry involved with metals is often more simple than incorporation of a specific 
template, metal-induced α-helices are often very metal specific and typically, as with covalent linking,  
require unnatural amino acids
9
. 
Among these methods, metal-ligand constraint, however, does provide several key advantages. In contrast 
to template and covalent systems, creation of the α-helix constrained organometallic compound can be 
achieved in either one or a very few number of simple steps. In comparison, the synthesis of the template 
alone takes many synthetic steps, and then the template must be incorporated into the peptide. RCM 
methods contain similar levels of complexity in the synthesis of unnatural amino acids. An 
organometallic compound containing a transition metal also provides a simple spectroscopic tool for 
a b 
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assessing the reactivity and behavior of the target in biochemical and biological settings. Additionally, the 
presence of a transition metal can help facilitate X-ray crystal structure elucidation due to its ability to 
restrict the peptides conformational fluxionality. Furthermore, the transition metal has the ability to 
undergo oxidation and reduction, enabling an investigation of how electronic transitions might affect the 
conformation of the complexed peptide. 
For the synthesis of peptides, although there are several currently available methods, solid phase peptide 
synthesis (SPPS) is the preferred method due to its robustness and efficiency
37
. For a majority of systems 
utilizing the range of previously mentioned constraints, the constraint was introduced after SPPS was 
complete and the peptide had been cleaved from the resin. Recently, however, researchers have developed 
methodologies for introducing the RCM and click reaction triazole covalent constraints while the peptide 
remains on the solid support
28,29,30
. As previously mentioned, however, both systems require the use of 
synthetic amino acids, limiting their potential in fully mimicking biological systems.  
Designing an analogous system which would utilize not only the advantages of metal-ligand based 
constraints but also the ease of on-resin complexation that would work with only the 20 common amino 
acids would be a significant advancement within the field.  
1.7 Thesis Work 
Previous research within the Curran lab
38
 has been successful at inducing a 310-helix, a helical structure 
that is slightly tighter than that of the α-helix, by crosslinking lysines at the i and i+3 positiong with 1,1'-
ferrocenedicarboxylic acid. By extending this previous research and redesigning its methodologies to 
work with solid phase peptide synthesis (SPPS) this thesis aims to develop and accomplish the synthesis 
of compound 1 (see Figure 1.10), an α-helix constrained organometallic.  
14 
 
 
 
 
Figure 1.10: Target organometallic compound. 
 
First, an attempt will be made to develop a method of synthesis for the compound compatible with SPPS. 
Once successful, coupling with ferrocene will be attempted while the peptide remains on its solid support 
in an effort to minimize polymerization and possibly improve yields (see Scheme 1.1). In the following 
chapters of this thesis is described the progress towards developing a methodology for the on-resin 
cyclization of a pentapeptide. Additionally discussed is a second methodology which utilizes SPPS to first 
synthesize a pentapeptid, which can then be cleaved and cyclized with ferrocene in solution phase. 
Scheme 1.1: 
 
 
 
. 
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MATERIALS AND METHODS 
 
2.1 Materials & Instrumentation 
Commercially available reagents and solvents were used for all purification and synthesis, unless 
otherwise noted. 1,1-ferrocenedicarboxylic acid and tetrakis(triphenylphosphine)palladium(0) were 
obtained from Strem Chemicals. Methanol, acetic anhydride, trifluoroacetic acid, tetrahydrofuran, 
diisopropylethylamine, dimethylformamide, chloroform, and ether were obtained from Fisher Chemicals. 
Anisole, oxalyl chloride and 1,8-diazabicycloundec-7-ene (DBU) were purchased from Sigma-Aldrich. 
All peptide reagents and peptide coupling reagents (HOBt, HATU) were from Chem-Impex International. 
For the ferrocene diacid chloride synthesis, dry CH2Cl2 was obtained from an anhydrous solvent 
purification apparatus. Prior to Aloc group removal, the scavenger agent, N-methylaniline was freshly 
distilled. Flash chromatography was performed using 60Ǻ pore Ultra Pure Silica Gel from Silicycle. Thin 
layer chromatography was performed using EMD chemicals TLC Silica gel 60 F254 glass backed plates. 
All NMR spectra were obtained with a 400 MHz Bruker Avance.  
2.2 Preparation of 1,1’-Ferrocenedicarboxylic Acid  Chloride39 
 
 
Scheme 2.1: Reaction scheme for the preparation of 1,1’-ferrocenedicarboxylic acid chloride 
First, 2.011 g (7.34mmol) of ferrocenedicarboxylic acid was reacted with 3.1 mL (4.9 equiv.) of oxalyl 
chloride and several drops of pyridine in 35mL of CH2Cl2. A cardboard box and aluminum foil were used 
to cover the reaction vessel to protect it from light. The reaction was stirred at room temperature for 12 
hours, followed by 6 hours at reflux. The CH2Cl2 was removed by rotary evaporation, and the product 
was left to dry overnight under vacuum. The desired product was extracted using approximately 5 x 100 
mL of boiling ligroin (≈80ºC) and subsequently decanting the ligroin into a second round bottom. The 
ligroin was subsequently removed using rotary evaporation, yielding 1.781g of red crystals (78% yield). 
The obtained crystals had a melting point of 91-95ºC, in close agreement with literature values (98ºC -
100ºC)
39
.  
1 2 
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2.3 Investigation of Solvent Effects on Allyloxycarbonyl (Aloc) Group Removal
40
 
 
Scheme 2.2: Solution phase Aloc removal  
First, 1.008g of Fmoc-Lys(Aloc)-OH was massed and transferred into two seperate reaction flasks. The 
reaction vessels were then sealed with a rubber septums and put under inert N2 atmosphere. For the first 
flask, labeled A, 0.0638g of tetrakis(triphenylphosphine)palladium(0) was dissolved into a solution of 
0.1:2:2:1 N-methylaniline:THF:DMF:0.5M HCl, quickly agitated, and added to the reaction flask using a 
syringe. For the second reaction flask, labeled B, 0.0638g of (triphenylphosphine)palladium(0) was 
dissolved into a solution of 0.1:2:2:1 N-methylaniline:THF:DMSO:0.5M HCl and added to the reaction 
flask using a syringe. The reactions were then stirred and monitored by TLC with samples taken every 60 
minutes for analysis. A 1:1 MeOH:CHCl3 was used as the eluent. To aid in the analysis, the reaction 
mixtures A and B were run in comparison to the unreacted Fmoc-Lys(Aloc)-OH starting material, labeled 
U on the TLC plates (Figure 2.1).  
 
Figure 2.1: TLC plates of Aloc removal reaction mixture with an eluent of 1:1 MeOH:CHCl3 
After 20 hours, both reactions were removed from stirring and the solvent solution was evaporated with a 
rotary evaporator. The crude product mixtures were then analyzed and compared using 
1
H NMR (Figures 
2.2, 2.3, and 2.4).  
17 
 
 
 
Figure 2.2: 
1
H NMR of Fmoc-Lys(Aloc) OH in DMSO-d6  
 
Figure 2.3: 
1
H NMR of crude product of Aloc removal attempted with DMF 
18 
 
 
 
 
Figure 2.4: 
1
H NMR of crude product of Aloc removal attempted with DMSO 
 
2.4 Preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
Scheme 2.3: Solid phase preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
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First 0.500g (0.365 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was added 
to a solid phase reaction vessel. Approximately 4.5mL (3x the resin volume) of CH2Cl2 was then added to 
the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH2Cl2 was 
subsequently drained and the resin was washed with 4.5mL of DMF with gentle agitation for 2 minutes, 
followed by draining. The DMF wash was performed 5 times. The Fmoc group was then removed using 
1.5mL (1x the resin volume) of a deprotecting solution (1:1:48 DBU:piperidine:DMF). The resin was 
washed 5 times with DMF in 2 minute intervals with gentle agitation and draining in between each rinse. 
A second round of DMF washes was then performed. To add the next amino acid, 0.826g (5 equiv) of 
Fmoc-Lys(Aloc)-OH and 0.682g of HATU (4.9 equiv) were first dissolved in a minimal amount (≈12mL) 
of DMF. Immediately prior to adding the peptide solution to the resin, 0.640mL of DIPEA were added to 
the peptide solution, the mixture was stirred, and subsequently added to the resin. After 1 hour of gentle 
agitation the remaining solution was drained off and the resin was once again washed with DMF as 
described above. The deprotection and DMF washes were then repeated. Next, 0.922g (5equiv) of Fmoc-
Val-OPfp and 0.253g (5 equiv) of HOBt were dissolved in a minimal amount of DMF and added to the 
reaction vessel. After agitation for 1 hour, the solution was then drained and the wash/deprotect/wash 
procedure was followed once again. Using this method 0.875g (5equiv) of Fmoc-Ala-OPfp and 0.829g (5 
equiv) Fmoc-Lys(Aloc)-OH were then added to the solid phase vessel and reacted. For the activated ester 
amino acids derivatives (those with a OPfp group) HOBt was utilized, whereas those with the unactivated 
amino acids (those with an OH) were coupled using the combination of HATU and DIPEA. After the 
resin was washed 5 times with DMF, 5 washes of deprotection solution, and 5 times with DMF, 0.345 mL 
(10 equiv.) of acetic anhydride in a minimal amount of DMF was added to the resin and allowed to react 
for 1 hour with gentle agitation.  
20 
 
 
 
2.5 Solution phase Ferrocene Coupling with Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
Scheme 2.4: Solution phase crosslinking of pentapeptide with ferrocene 
In addition to the attempted on-resin coupling, a solution phase methodology for crosslinking the 
synthesized pentapeptide with ferrocene was also attempted. First 0.0946 g (1 equiv) of dried resin was 
transferred to a second reaction vessel. The peptide was cleaved from the resin via the addition of 3mL 
(3x the resin volume) of 95:2.5:2.5 TFA:anisole:H2O v/v solution with gentle agitation for 3 hours. The 
solution within the reaction vessel was then drained into a round bottom flask. The resin was 
subsequently washed 2 times with 3mL of TFA and combined with the previous removal solution 
fractions. After the solvent was evaporated using a high vacuum rotary evaporator, the resulting product 
was then triturated with ether several times to remove impurities. The 
1
H NMR of the product was 
consistent with the desired pentapeptide. COSY and 
1
H NMR were utilized to make peak assignments for 
each hydrogen found within the product (Figure 2.5, Table 2.1, Figure 2.6, Table 2.2). 
21 
 
 
 
Figure 2.5: 
1
H NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
in DMSO-d6. 
Table 2.1: Peak Data for 
1
H NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
in DMSO-d6. 
δ (ppm) Integral splitting J-Coupling Identity 
8.09 1 H m  
 
Ala-NH 
8 1 H m  
 
Gly-NH 
7.97 1 H m  
 
Lys-NH 
7.75 1 H d 3J: 7.58 Hz Lys-NH 
7.69 1 H d 3J: 8.37 Hz Val-NH 
7.15 1 H m  
 
Lys-Amine 
7.07 1 H m  
 
Lys-Amine 
6.96 2 H s 
 
Terminal Amide 
5.89 2 H o 
 
Aloc-CH 
5.25 2 H dd 2J:  17.52 Hz, 3J: 1.78 Hz Aloc Terminal CH 
5.15 2 H dd 2J:  10.48 Hz, 3J: 1.57 Hz Aloc Terminal CH 
4.44 4 H d 3J: 5.45 Hz Aloc-CH2 
4.3 1 H m 
 
Ala-CαH 
4.2 1 H m 
 
Lys-CαH 
4.15 1 H m 
 
Lys-CαH 
4.11 1 H m 
 
Val-CαH 
3.60 2 H m 
 
Gly-CαH 
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2.93 2 H m 
 
Lys-N-CH2 
2.93 2 H m 
 
Lys-N-CH2 
1.97 1 H m 
 
Val-CβH 
1.83 3 H s 
 
Ac-CH3 
1.69-1.21 13 H m 
 
Lys-CH2 
1.19 3 H m  
 
Ala-CH3 
0.82 6 H d 3J: 10.90 Hz Val-CH3 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: 2D COSY NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
in DMSO-d6. 
Table 2.2: Cross Coupling Peaks for COSY of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
in DMSO-d6. 
Cross Peak Coupling Hydrogens 
Ala-NH (8.09ppm) with Ala-Cα-H (4.30ppm) 
Gly-NH (8.00ppm) with Gly-Cα-H (3.60ppm) 
Lys-NH (7.97ppm) with Lys-Cα-H (4.20ppm) 
Lys-NH (7.75ppm) with Lys-Cα-H (4.15ppm) 
Val-NH (7.69ppm) with Val-Cα-H (4.11ppm) 
Lys-Amine (7.15ppm) with Lys-CH2-N (2.93ppm) 
Lys-Amine (7.07ppm) with Lys-CH2-N (2.93ppm) 
Aloc-CH (5.89ppm) with Aloc-CH2 (4.44ppm) 
Aloc-CH (5.89ppm) with Aloc Terminal CH (5.25ppm) 
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Aloc-CH (5.89ppm) with Aloc Terminal CH (5.15ppm) 
Aloc Terminal CH (5.25ppm) with Aloc-CH2 (4.44ppm) 
Aloc Terminal CH (5.15ppm) with Aloc-CH2 (4.44ppm) 
Ala-Cα-H (4.30ppm) with Ala-CH3 (1.19ppm) 
Lys-Cα-H (4.20ppm) with Lys-CH2 (1.69-1.21ppm) 
Lys-Cα-H (4.15ppm) with Lys-CH2 (1.69-1.21ppm) 
Val-Cα-H (4.11ppm) with Val-Cβ-H (1.97ppm) 
Lys-CH2-N (2.93ppm) with Lys-CH2 (1.69-1.21ppm) 
Val-Cβ-H (1.97ppm) with Val-CH3 (1.69-1.21ppm) 
Lys-CH2 (1.69-1.21ppm) with Lys-CH2 (1.69-1.21ppm) 
 
The allyloxycarbonyl (Aloc) groups on the two lysine residues at i and i+3 positions within the peptide 
were then removed by reaction with a solution of 2:2:1:0.1 DMF:THF:0.5M HCl: freshly distilled N-
methylaniline v/v solution (≈ 5.1mL/100mg resin). In this reaction Pd(PPh3)4 was used as a catalyst with a 
0.25 equivalent load (0.01995g). To protect the catalyst, the reaction was run under inert N2 atmosphere. 
The reaction was left stirring for 24 hours and the solvent was subsequently removed under high vacuum. 
Upon heating to remove the solvent, the solution transitioned from a light yellow color to a dark purple. 
The color change was attributed to the poisoning of the Pd catalyst.  
Ferrocene crosslinking was then attempted with the crude product. The unpurified mixture was first 
dissolved in approximately 12.5mL of DMF. A solution of 0.0215g (1 equiv) of 1,1’-
ferrocenedicarboxylic acid chloride in 5 mL of DMF was first added to a stirring solution of the crude 
unprotected peptide followed by the addition of 115µL of DIPEA. The coupling reaction was conducted 
under inert N2 atmosphere. After 24 hours, the solvent was then removed using a high vacuum rotary 
evaporator. Due to the known impurity of the product, no accurate mass of the desired product could be 
obtained, but the mass of the crude sample was approximately 150mg.  
The 
1
H NMR of the product indicates that complete removal of the Aloc group was incomplete (Figure 
2.7). 
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Figure 2.7: 
1
H NMR of solution phase cyclization attempt with unpurified peptide 
 
Based on integration values, about 50% of the Aloc groups were removed. Despite this, the 
1
H NMR also 
indicates the presence of peaks in the 4.5-5ppm region, characteristic of ferrocene being present, so flash 
chromatography was attempted. Flash chromatography, with an eluent of 10:1 chloroform:methanol, was 
used to separate the product mixture. The crude product was then dissolved in a minimal amount of HFIP 
and added to the packed 1.5cm column. A total of 36 2mL fractions from the column were collected and 
analyzed using thin layer chromatography (TLC). Due to the difficulty of separation to obtain a pure 
crosslinked product, purification was halted.  
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2.6 Preparation of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 
 
Scheme 2.5: Solid phase preparation of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 
 
First 0.1028g (0.07504 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was 
added to a solid phase reaction vessel. Approximately 3.0mL (3x the resin volume) of CH2Cl2 was then 
added to the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH2Cl2 
was subsequently drained and the resin was washed with 3mL of DMF with gentle agitation for 2 
minutes, followed by draining. The DMF wash was performed 5 times. The Fmoc group was then 
removed using a 1.0mL (1x the resin volume) a deprotecting solution (1:1:48 DBU:piperidine:DMF). The 
resin was washed 5 times with DMF in 2 minute intervals with gentle agitation and draining in between 
each rinse. A second round of DMF washes was then performed. To add the next amino acid, 0.1920g (5 
equiv) of Fmoc-Lys(Z)-OH and 0.1399 of HATU (4.9 equiv) were first dissolved in a minimal amount 
(≈4mL) of DMF. Immediately prior to adding the peptide solution to the resin, 0.130mL (10 equiv) of 
DIPEA were added to the peptide solution, the mixture was stirred, and subsequently added to the resin. 
After 1 hour of gentle agitation the remaining solution was drained off and the resin was once again 
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washed with DMF as described above. The deprotection and DMF washes were then repeated. Next, 
0.1911g (5equiv) of Fmoc-Val-OPfp and 0.0517g (5 equiv) of HOBt were dissolved in a minimal amount 
of DMF and added to the reaction vessel. After agitation for 1 hour, the solution was then drained and the 
wash/deprotect/wash procedure was followed once again. Using this method 0.1808g (5equiv) of Fmoc-
Ala-OPfp and 0.1691g (5 equiv) Fmoc-Lys(Z)-OH were then added to the solid phase vessel and reacted. 
For the activated amino acids (those with a OPfp group) HOBt was utilized, whereas with the unactivated 
amino acids (those with an OH) were coupled using the combination of HATU and DIPEA. After the 
resin was washed 5 times with DMF, 5 washes of deprotection solution, and 5 times with DMF, 0.345 mL 
(10 equiv.) of acetic anhydride in a minimal amount of DMF (≈1.5mL) was added to the resin and 
allowing to react for 1 hour with gentle agitation. After draining and washing with DMF (5×3mL) The 
resin was subsequently dried under N2. The peptide was then cleaved from the resin using 3mL of a 
removal solution of 95:2.5:2.5 TFA:anisole:H2O v/v solution with gentle agitation for 3 hours. 
Subsequently, the resin was washed with 2mL of TFA for 2 minutes and all of the filtrates were collected 
in a single round bottom flask. The solvent was then evaporated off yielding a crude mass of 0.64mg. The 
1
H NMR of the product was consistent with the desired pentapeptide. COSY and 
1
H NMR were utilized 
to make peak assignments for each hydrogen found within the product (Figure 2.8, Table 2.3, Figure 2.9, 
Table 2.4). 
 
Figure 2.8: 
1
H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6 
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Table 2.3: Peak data for the 
1
H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6 
δ (ppm) Integral Splitting J-Coupling Identity 
8.11 1 H m 
 
Ala-NH 
8.05 1 H m  
 
Gly-NH 
8 1 H m 
 
Lys-NH 
7.77 1 H d 3J: 7.89 Hz Lys-NH 
7.71 1 H d 3J: 8.97 Hz Val-NH 
7.34 10 H m 
 
Cbz-Benzyl 
7.23 1 H m 
 
Lys-Amine 
7.11 1 H m 
 
Lys-Amine 
6.89 2 H s 
 
Terminal Amide 
5 4 H s 
 
Cbz-CH2 
4.3 1 H m 
 
Ala-CαH 
4.2 1 H m 
 
Lys-CαH 
4.15 1 H m 
 
Lys-CαH 
4.11 1 H m 
 
Val-CαH 
3.67 2 H m  
 
Gly-CαH 
2.95 2 H m 
 
Lys-N-CH2 
2.95 2 H m 
 
Lys-N-CH2 
1.97 1 H m 
 
Val-CβH 
1.83 3 H s 
 
Ac-CH3 
1.69-1.21 13 H m 
 
Lys-CH2 
1.19 3 H m  
 
Ala-CH3 
0.82 6 H d 3J: 10.90 Hz Val-CH3 
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Figure 2.9: 2D COSY NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
in DMSO-d6. 
 
Table 2.4:Cross Coupling Peak data for the 
1
H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6 
Cross Peak Coupling Hydrogens 
Ala-NH (8.11ppm) with Ala-Cα-H (4.30ppm) 
Gly-NH (8.05ppm) with Gly-Cα-H (3.67ppm) 
Lys-NH (8.00ppm) with Lys-Cα-H (4.20ppm) 
Lys-NH (7.77ppm) with Lys-Cα-H (4.15ppm) 
Val-NH (7.71ppm) with Val-Cα-H (4.11ppm) 
Cbz-Benzyl (7.34ppm) with Cbz-Benzyl (7.34ppm) 
Lys-Amine (7.23ppm) with Lys-CH2-N (2.95ppm) 
Lys-Amine (7.11ppm) with Lys-CH2-N (2.95ppm) 
Ala-Cα-H (4.30ppm) with Ala-CH3 (1.19ppm) 
Lys-Cα-H (4.20ppm) with Lys-CH2 (1.69-1.21ppm) 
Lys-Cα-H (4.15ppm) with Lys-CH2 (1.69-1.21ppm) 
Val-Cα-H (4.11ppm) with Val-Cβ-H (1.97ppm) 
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Lys-CH2-N (2.95ppm) with Lys-CH2 (1.69-1.21ppm) 
Val-Cβ-H (1.97ppm) with Val-CH3 (1.69-1.21ppm) 
Lys-CH2 (1.69-1.21ppm) with Lys-CH2 (1.69-1.21ppm) 
 
2.7 Solution Phase synthesis of Ferrocene Crosslinked Ac-Lys-Ala-Val-Lys-Gly-NH2 
 
Scheme 2.6: Solution phase cyclization using Z protected peptide 
To begin, all of the resin cleaved pentapeptide, Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2, product from the 
previous step (≈50mg) was dissolved in 12.5mL of DMF and transferred to a Parr hydrogenation flask. 
Under a stream of running N2, 0.0267g of 5% Pd on C was then added to the solution. The flask was then 
placed in a Parr hydrogenation apparatus and hydrogenated for 24 hours at 40psi. The catalyst was 
subsequently removed via vacuum filtration through celite into a three neck flask. The solution was then 
brought to a total volume of 70mL of DMF. An addition funnel was added and the system was put under 
N2. 0.191g of ferrocene dicarboxylic acid chloride was dissolved in 10mL of DMF and added to the 
addition funnel. To the solution was then added 0.250mL of DIPEA via a syringe. The ferrocene 
dicarboxylic acid chloride solution was then added to the reaction flask over the course of an hour and the 
reaction was allowed to stir for 24 hours. The bronze colored solution was then transferred to a second 
flask and the DMF was evaporated using a rotary evaporator. The crude mixture was then washed with 
MeOH and the MeOH was decanted into a second round bottom flask. The MeOH was then evaporated to 
yield a crude black film with a mass of 50mg. The 
1
H NMR indicates that there is ferrocene in the product 
mixture (Figure 2.10). 
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Figure 2.10: Crude solution phase ferrocene cyclized product using Z protected peptide  
 
Flash chromatography was attempted on the crude mixture, but after evaporation, the obtained black film 
was no longer soluble in MeOH. Due to time constraints, flash chromatography could not be fully 
completed, although intial TLC analysis indicated that pure MeOH was not a sufficient eluent and that 
acetic acid must be added for adequate separation. It is also noted that upon dissolution in DMF, the black 
film had a redish tint, indicative of the presence of ferrocene.   
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2.8 Preparation of Ferrocene Crosslinked Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 On-resin 
 
Scheme 2.7: On resin preparation of Ferrocene crosslinked Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
To begin 0.1019g (0.07439 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was 
added to a solid phase reaction vessel. Approximately 3.0mL (3x the resin volume) of CH2Cl2 was then 
added to the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH2Cl2 
was subsequently drained and the resin was washed with 3.0mL of DMF with gentle agitation for 2 
minutes, followed by draining. The DMF wash was performed 5 times. The Fmoc group was then 
removed using 1.0mL of a deprotecting solution (1:1:48 DBU:piperidine:DMF). The resin was washed 5 
times with DMF in 2 minute intervals with gentle agitation and draining in between each rinse. A second 
round of DMF washes was then performed. To add the next amino acid, 0.1695g (5 equiv) of Fmoc-
Lys(Aloc)-OH and 0.1383g of HATU (4.9 equiv) were first dissolved in a minimal amount (≈4mL) of 
DMF. Immediately prior to adding the peptide solution to the resin, 0.1296mL of DIPEA were added to 
the peptide solution, the mixture was stirred, and subsequently added to the resin. After 1 hour of gentle 
agitation the remaining solution was drained off and the resin was once again washed with DMF as 
described above. The deprotection and DMF washes were then repeated. Next, 0.1923g (5equiv) of 
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Fmoc-Val-OPfp and 0.0514g (5 equiv) of HOBt were dissolved in a minimal amount of DMF (≈4mL) 
and added to the reaction vessel. After agitation for 1 hour, the solution was then drained and the 
wash/deprotect/wash procedure was followed once again. Using this method 0.1529g (5equiv) of Fmoc-
Ala-OPfp and 0.1691g (5 equiv) Fmoc-Lys(Aloc)-OH were then added to the solid phase vessel and 
reacted. For the activated ester amino acid derivatives (those with a OPfp group) HOBt was utilized, 
whereas with the unactivated amino acids (those with an OH) were coupled using the combination of 
HATU and DIPEA. After the resin was washed 5 times with DMF, 5 washes of deprotection solution, and 
5 times with DMF, 0.070 mL (10 equiv.) of acetic anhydride in a minimal amount of DMF was added to 
the resin and allowing to react for 1 hour with gentle agitation. The resin was then dried under N2 and 
subsequently swelled for 30 minutes using CH2Cl2. After draining off the CH2Cl2, the reaction vessel was 
covered with aluminum foil and flushed with N2. Next, 0.0872g (1 equiv) of 
tris(triphenylphosphine)palladium(0) and 0.1055g (10 equiv) of dimedone were then dissolved in a 
solution of dry, degassed CH2Cl2 and THF (0.5mL:0.5mL). Using a syringe this solution was then added 
to the reaction vessel and agitated using a shaker for 6 hours. The solution was then drained and the resin 
was washed with 0.5% v/v DIPEA in DMF (5×10mL), 0.5% w/v dimethylddithiocarbamic acid soldium 
salt solution (10×10mL), dry CH2Cl2 (5×10mL) and dry diethylether (5×5mL). The resin was then dried 
under vacuum for several minutes. In order to crosslink the deprotected peptide, after flushing the 
reaction vessel with N2, 0.0261g (1.13equiv) of 1,1’-ferrocene dicarboxylic acid chloride in 1mL of DMF 
was added to the resin in addition to 0.130mL of DIPEA and the reaction vessel was shaken. After 96 
hours, the reaction vessel was drained and subsequently washed with DMF (5×4mL) in two minute 
intervals. In order to acylate any unreacted free amines, 0.070mL (10 equiv) of acetic anhydride was 
dissolved in 1mL of DMF and subsequently added to the resin. After 1 hour of shaking, the solution was 
drained and washed with DMF once again. The resin was subsequently dried under N2 and the peptide 
was cleaved from the resin using a removal solution of 95:2.5:2.5 TFA:anisole:H2O v/v solution with 
gentle agitation for 3 hours. The resin was then finally washed with two volumes of TFA for 2 minutes 
and all of the filtrates were collected in a single round bottom flask. The solvent was then evaporated off 
using a rotary evaporator yielding a crude mass of 0.1052g. The 
1
H NMR of the crude product does not 
contain any substantial peaks within the 4.5-5.0ppm region, characteristic of ferrocene Cp rings (Figure 
2.11). Due to absence of ferrocene peaks, no purification attempt was made of the crude product.  
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Figure 2.11: Crude on resin ferrocene cyclization with Aloc protected peptide 
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RESULTS AND DISCUSSION 
The goal of this study was to successfully synthesize a pentapeptide with lysine residues at the i and i+3 
positions which could be crosslinked with 1,1’-ferrocenedicarboxylic acid chloride while still on-resin. 
For the on resin synthesis, Fmoc based solid phase peptide synthesis (SPPS) was utilized. SPPS is 
advantageous due to the high purity and efficiency it affords in comparison to solution phase peptide 
synthesis. In SPPS, the amino acid is immobilized on the surface of an insoluble polymer This 
methodology allows for sequential addition of amino acids to the N-terminus of the immobilized amino 
acid, enabling precise control of peptide assembly. During synthesis, the terminal amino acid is 
deprotected and the next amino acid is added. This process is repeated until the desired peptide is 
synthesized. Subsequently, the peptide chain is cleaved from the resin and desired product is obtained. 
Currently, there are two major protecting groups compatible with SPPS: Fmoc and Boc. Fmoc based 
SPPS was chosen over Boc based systems due to the milder reaction conditions and lack of special 
equipment required for the synthesis. Additionally, the highly acidic conditions for Boc removal would 
lead to premature cleavage of the peptide from the resin compatible with the possible on resin cyclization. 
To begin, 1,1’-ferrocenedicarboxylic acid chloride was prepared using previously published syntheses1 
(Scheme 3.1). 
3.1 Preparation of 1,1’-Ferrocenedicarboxylic Acid  Chloride1 
 
Scheme 3.1: Reaction scheme for the preparation of 1,1’-ferrocenedicarboxylic acid chloride 
This methodology requires that the reaction be kept in the dark for 12 hours. Aluminum foil covering the 
flask was found to be sufficient. To limit exposure to water vapor, the reaction was also run with a rubber 
septum pierced with a syringe tip for ventilation. In order to confirm the product, melting point analysis 
was performed on the resulting red/crimson solid. The melting point was found to be 87°C-95°C, slightly 
lower than the reported literature value of 98°C-100°C. It is assumed that trace impurities are responsible 
for the slightly lower experimental value determined. The main source of impurities for the formed diacid 
chloride is hydrolysis to the starting dicarboxylic acid product, which has a melting point of 210°C-
215°C. Given that the experimental value was lower than reported, it was assumed that this impurity was 
present only in trace amounts. In order to prolong the life of the 1,1’-ferrocenedicarboxylic acid chloride 
2 1 
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product, the solid was kept under either N2 or vacuum in a refrigerator. Additionally, prior to each use, the 
crude product was washed redissolved with dry ethyl ether, filtered to remove impurities, and the solvent 
was evaporated to ensure purity as the diacid chloride is soluble in ether, whereas, the diacid is not. The 
experimental yield of 78% was comparable to the published results, validating this as an effective 
methodology for the preparation of 1,1’-ferrocenedicarboxylic acid chloride. 
3.2 Preparation of Ferrocene Crosslinked Ac-Lys-Ala-Val-Lys-Gly-NH2 
In the first attempt, the entire synthesis of Ac-Lys-Ala-Val-Lys-Gly-NH2 cyclized on resin with ferrocene 
was carried out in its entirety (Scheme 3.2) 
 
Scheme 3.2: On-resin cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 
To begin, the pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 was prepared on resin. This was 
accomplished using Fmoc solid phase peptide synthesis (SPPS).  
For the synthesis, Fmoc-protected amino acids and Aloc-protected lysines residues were utilized due to 
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the mild conditions under which they are removed. This allowed for the use of a Rink Amide AM resin, 
which is cleaved under acidic conditions. In order to place lysine residues at the i and i+3 positions, only 
a tetrapeptide is required. The only commercially available lysine bound Rink Amide AM resin, however, 
has a Boc side chain protecting group. Boc groups are easily cleaved under the same conditions as the 
Rink Amide AM resin, making it unusable for our purposes. Due to the fact that the lysine residue could 
not be placed on the C-terminus, a glycine bound Rink Amide AM resin was utilized. A glycine residue 
was chosen due to its minimal steric bulk. Therefore a pentapeptide, rather than a tetrapeptide was 
synthesized. In addition all amino acids were used in their carboxylic acid or OPfp ester forms and 
activated using coupling reagents during synthesis. In particular the use of OSu derivatives was avoided 
due to previous studies which have shown that even in the presence of HOBt, reactions with OSu esters 
tend to be slow and form unwanted side products
41
. 
The first steps of SPPS are relatively simple. In order for efficient reaction, the dried resin must first be 
swollen to allow adequate access to the resin bound amino acid. This is done by adding the dried resin to 
the solid phase vessel and swelling with CH2Cl2 for 30 minutes with agitation. The Fmoc protecting 
group is then removed via a series of washes, followed by addition of the next amino acid dissolved in a 
minimal amount of DMF. The reaction was then gently agitated by shaking for one hour. The resin was 
then washed and the Fmoc group was once again removed, followed by subsequent addition of the next 
amino acid. This process could then be repeated as many times as necessary to complete synthesis of the 
desired peptide. In this manner, alloxycarbonyl protected lysine, valine, alanine, and alloxycarbonyl 
protected lysine were added to form the desired pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2. 
The lysine derivatives were purchased in their carboxylic acid form, and as such required activation for 
effective addition. This was accomplished using in situ generation of the activated ester derivative by 
reaction with HATU and DIPEA (Scheme 3.3). 
  
Scheme 3.3: In situ activation of carboxylic acid amino acids with HATU 
All other amino acids were used as OPfp activated esters. Although not required, HOBt was used to 
activate these amino acids in situ in order to increase yields. The generation of the activated ester is very 
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similar to that of HATU (Scheme 3.4). 
  
Scheme 3.4: In situ activation of the OPfp amino acids 
Finally, the Fmoc group was removed from the terminal residue and an acetyl group was added via the 
addition of acetic anhydride in DMF to the resin, in the same manner as the previous amino acids. It is 
important to note that these groups were removed due to the lability of Fmoc protecting groups under 
basic conditions and their tendency to make reaction mixtures more difficult to separate. 
Aloc group removal was then attempted. Prior to reaction, the tetrakistriphenylphosphinepalladium(0) 
catalyst was washed with methanol to remove impurities. The solution was then decanted and discarded 
while the remaining solid was placed under vacuum to remove any remain MeOH. The reaction vessel 
was then drained and purged with flowing N2. Tetrakistriphenylphosphinepalladium(0), dissolved in 5mL 
of 2:2:1:0.5 solution of DMF:THF:0.5M HCl: N-methylaniline was then added to the reaction flask. The 
resin was subsequently washed and repurged with N2. Cyclization was then attempted via the addition of 
1,1’-ferrocenedicarboxylic acid chloride and DIPEA as a base. In order to gauge and potentially quantify 
the amount of free amine present (if any) in the resulting product, the resin was treated with acetic 
anhydride in DMF for 1 hour prior to resin cleavage. In order to remove the cyclized peptide from the 
solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours. The 
resulting solution was then drained into a flask and freeze dried overnight. The pale pink solid was then 
characterized via 1D 
1
H NMR, 2D 
1
H NMR COSY and ROESY, as well as circular dichroism. Initial 
1
H 
NMR data indicated that the Aloc groups had not been successfully removed (Figure 3.1). 
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Figure 3.1: Crude product from on-resin Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 with Ferrocene 
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3.3 Solid Phase Preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2
 
Scheme 3.4: Solid phase preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
As stated, during the characterization of the on-resin cyclization product, the reaction was also attemped 
off-resin. First, the dried resin was added to the solid phase vessel and the resin was swelled with CH2Cl2 
for 30 minutes with agitation. The Fmoc protecting group was then removed via a series of washes, 
followed by addition of the next amino acid dissolved in a minimal amount of DMF. The reaction was 
then gently agitated by shaking for one hour. The resin was then washed and the Fmoc group was once 
again removed, followed by subsequent addition of the next amino acid. This process could then be 
repeated as many times as necessary to complete synthesis of the desired peptide. In this manner, 
alloxycarbonyl protected lysine, valine, alanine, and alloxycarbonyl protected lysine were added to form 
the desired pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2. In order to remove the peptide from 
the solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours.  After 
rotary evaporation, the resulting peptide was triturated with diethyl ether to yield a beige solid.  
This solid was characterized by 1D 
1
H NMR, which indicated that the desired product was present with 
little to no impurities. To confirm the peak assignments a 2D 
1
H COSY, which exhibits crosspeaks for 
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hydrogens one bond apart, was obtained. The exhibited cross peaks were consistent with the initial 
assignments from 1D 
1
H NMR. An MS of the resulting product was not obtained because the instrument 
was not working at the time, but based on consistency of the 1D and 2D 
1
H NMR data, it was assumed 
that the peptide was successfully synthesized.  
3.4 Solution Phase Aloc Deprotection of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
Using the off-resin pentapeptide, a solution phase removal of the protecting Aloc groups was attempted. 
The previously prepared pentapeptide was first placed under an inert atmosphere of N2 in a round bottom 
flask. To the flask was then added tetrakistriphenylphospinepalladium(0) (purified as previously 
discussed) in 5mL of a 2:2:1 solution of DMF:THF:0.5M HCl with N-methylaniline as the organic 
scavenger. After addition of the removal solution via a syringe, the reaction was monitored via TLC. 
Samples of the product mixture were then taken every 45 minutes for 7 hours. Within this time period, no 
noticeable difference in the Rf was observed, with all plates exhibiting 3 major spots with Rf values of 
0.96, 0.91, and 0 respectively.  
 
Figure 3.2: TLC of Aloc removal reaction mixture run with 1:1 CHCl3:MeOH mixture.  
 
The reaction was run overnight and a final sample was analyzed via TLC, but no measurable differences 
in Rf values were observed. A 1D 
1
H NMR was then taken of the crude product mixture to determine the 
efficiency of the Aloc removal.  
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Figure 3.3: 
1
H NMR of crude solution phase Aloc removal product in DMSO-d6 
Within the 
1
H NMR spectrum, the Aloc peaks can still be observed, indicating that once again, the Aloc 
group removal was incomplete. Using the integration values of the Aloc peaks, the efficiency of the 
reaction was then be estimated. The complete peptide contains two Aloc groups, meaning that the 
integration values should be 2:2:2:4 for the assigned peaks in Figure 3.3. The experimental values, 
however, are half of the expected values, indicating that only about ½ of the Aloc groups are being 
removed from the peptide. There are several factors which could have contributed to the lack of 
success/efficiency. Due to the sensitivity of the Pd(0) catalyst, it was hypothesized that the catalyst 
precursor was either no longer active or that the active catalyst was being poisoned during the reaction by 
impurities in the N-methylaniline scavenger. In order to avoid this complication, the reaction was then run 
in the same manner but using freshly distilled N-methylaniline. It is of note that the freshly distilled N-
methylaniline was significantly paler after distillation and noticeably more viscous. Once again, TLC was 
used to monitor the reaction, but no observable differences in Rf values were observed across the reaction 
duration. The observed spots had Rf values of 0.95, 0.88, 0.77, and 0 with an eluent of 1:1 CHCl3:MeOH 
(Figure 3.4).  
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Figure 3.4: TLC plate of off-resin solution phase Aloc removal crude reaction mixture 
 
Given the fast elution of two major compounds on the TLC plates, it is assumed that the lack of difference 
in the collected reaction plates may be due to the use of too polar of an eluent. The solvent was then 
evaporated using a rotary evaporator and the resulting product was characterized via 1D 
1
H NMR (Figure 
3.5).   
 
Figure 3.5: 
1
H NMR of crude product mixture of Aloc removal attempted with distilled N-methylaniline 
Within the 
1
H NMR, the Aloc peaks have almost entirely disappeared, indicating that removal was mostly 
successful. Once again, using the integration values, the removal percentage can be estimated. Using the 
Val CH3 groups as a standard, the reaction was calculated to have removed approximately 75% of the 
43 
 
 
 
Aloc protecting groups. With the relative success of the Aloc removal, it was assumed that impurities in 
the undistilled N-methylaniline were mostly responsible for poisoning the catalyst in previous attempts. 
Due to the reactivity of the free amines in the unprotected pentapeptide, synthesis was continued without 
purification of the crude product mixture. 
3.5 Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 
With a majority of the Aloc protecting groups successfully removed, cyclization was attempted in 
solution phase (Scheme 3.5). 
Scheme 3.5: Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 
Before the reaction could be conducted, the small volume of DMSO-d6 used as the NMR solvent was 
evaporated off. During the process, it was observed that the product mixture turned from yellow to purple 
upon heating. It is believed that the observed color change is mostly due to degradation of the Pd(0) 
catalyst. For the synthesis, the crude product mixture was first placed under an inert N2 gas atmosphere. 
1,1’-ferrocenedicarboxylic acid chloride, dissolved in DMF and an excess of DIPEA were then added via 
a syringe and the reaction mixture was stirred. The cyclization was allowed to run for 94 hours. The 
solvent was then evaporated using a rotary evaporator and a 1D 
1
H NMR of the crude product mixture 
was taken.  
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Figure 3.6: 
1
H NMR of crude solution phase cyclization product 
Having not previously removed the Pd(0) catalyst, there were a large number of impurities present in the 
crude mixture. In addition, the 
1
H NMR shows that the Aloc protected impurities are also present. 
Although the NMR displays several promising peaks, full characterization of the products would require 
1
H NMR data of a higher resolution. Purification by flash chromatography was then attempted using a 
10:1 eluent of chloroform:methanol. The crude product was first dissolved in a minimal amount of 
hexafluoropropanol and added to a packed column. The fractions were then compared via TLC. 
 
Figure 3.7: TLC analysis of FC fractions 1-8 of solution phase cyclization of pentapeptide 
 
As shown by both TLC and 
1
H NMR analysis, little separation was accomplished using this method. To 
confirm, fraction 5, which contained several spots which appeared orange, was isolated and an 
1
H NMR 
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was recorded. The 
1
H NMR spectrum, however, did not provide sufficient resolution to confirm the 
product. The spots shown in Figure 3.7 which remained on the origin, were purple, and therefore, it was 
assumed that they were primarily Pd catalyst. Other fractions were not isolated due to the prevalence of 
the palladium catalysts throughout the column, which after loading, was entirely purple in color due to the 
lack of separation. It is believed that most of the crude mixture, which was insoluble in most organic 
solvents, preferentially stayed dissolved in the HFIP. As an extremely polar molecule, HFIP moves fairly 
quickly through the column, and as a result, most of the product ran too quickly, resulting in minimal 
separation. Given that the product mixture had so many impurities, purification techniques were halted. 
Instead, having proven successful Aloc group removal using freshly distilled N-methylaniline, the on-
resin cyclization was once again reattempted.  
3.6 On-resin cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 
 
Scheme 3.6: On-resin cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 with distilled N-methylaniline 
Having successfully removed a majority of the Aloc groups in a solution phase reaction with freshly 
distilled N-methylaniline, the on-resin deprotection and cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-
Gly-NH2 was then reattempted. SPPS should also make the isolation of the final product more efficient. 
First, the pentapeptide, Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2, was prepared using SPPS, as 
previously described. To the resin, under inert N2 atmosphere, was then added 
tetrakistriphenylphosphinepalladium(0) (purified as previously discussed) dissolved in 5mL of a 2:2:1 
solution of DMF:THF:0.5M HCl with freshly distilled N-methylaniline. The reaction was then agitated 
for 13 hours under flowing N2. Upon returning to the laboratory, it was noted that all of the solvent had 
evaporated in the elapsed time. As a result, 5mL of the reaction solution were then added once again and 
the reaction was agitated for an additional 13 hours without flowing N2. The resin was then washed and 
repurged with N2. A solution of 1,1’-ferrocenedicarboxylic acid chloride in DMF was then added to the 
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resin and the reaction mixture was agitated for 74 hours. The resin was then washed and treated with 
acetic anhydride in DMF. The peptide was then removed from the resin and the solvent was evaporated. 
1D 
1
H NMR and 2D 
1
H COSY spectra were then taken for the crude product.  
Figure 3.8: On resin cyclization attempt with distilled N-methylaniline 
Similar to the solution phase deprotection, based on integration values, the Aloc deprotection step was 
found to only be about 75% effective. Before full synthesis could be carried out again, it was decided that 
a more effective method must first be developed for the peptide deprotection in order to maximize 
product purity and yields.  
3.7 Solvent effects on Aloc deprotection efficiencies 
It is widely known that catalysis can be highly dependent on the solvent within which the reaction is run. 
In all of the attempted synthesis, a mixture of DMF, THF, and 0.5M HCl had been utilized in contrast to 
literature reports which used DMSO instead of DMF. While the two are both polar aprotic solvents, side 
by side reactions were run in order to detect any differences in the purity/efficiency. For ease, the Aloc 
removal was performed on Fmoc-Lys(Aloc)-OH in solution phase. 
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Scheme 3.7: Aloc deprotection efficiencies using DMSO or DMF 
To simplify the comparison, the two reactions were run using equal amounts of each reagent for identical 
durations. First, the protected amino acid was placed in a round bottom flask and placed under an inert N2 
atmosphere. To the reaction flask was then added 5mL of a 2:2:1 solution of Solv:THF:0.5M HCl where 
the solvent was either DMF or DMSO. It is noted that the Pd(0) catalyst precursor was significantly more 
soluble in DMSO  than in DMF initially. The solutions were then added via a syringe to the flasks and the 
reactions were stirred for 24 hours. The reaction mixture was monitored via TLC with samples taken 
every hour. Across the reaction time, as was found with previous Aloc removal studies, there was no 
significant difference observed in the Rf values of the spots. After the allotted reaction time, the solvents 
were evaporated from each sample and 1D 
1H NMR’s of each were taken (Figure 3.9) 
Figure 3.9: Aloc deprotection of Fmoc-Lys(Aloc)-OH with different solvents 
From the 
1
H NMR, both methods were shown to effectively remove the protecting Aloc groups. It is 
noted that the conversion efficiency within this simple system was almost 25% more effective than that of 
on-resin Aloc removal. It is therefore proposed that on-resin deprotection is slightly less effective 
DMF 
DMSO 
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possibly due to accessibility issues. Given the limited success on-resin, alternative methods of Aloc 
deprotection were then investigated. 
3.8 On-resin Aloc Deprotection of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 with Dimedone
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After performing a literature search, an alternative method for Aloc removal utilizing dimedone as the 
scavenger was found. This previously published method
2
 was then applied to the system at hand.  
Scheme 3.8: On-resin cyclization of pentapeptide using Dimedone as scavenger 
First, the pentapeptide was synthesized using SPPS as was accomplished earlier. Prior to catalyst 
addition, the reaction vessel was purged with N2 and covered with aluminum foil to exclude light. To the 
swollen resin, was then added 1 equivalent of tetrakistriphenylphosphinepalladium (0) (purified as 
previously discussed) and 10 equivalents of dimedone in 2mL of a 1:1 solution of CH2Cl2:THF. The 
solution was then agitated for 6 hours and subsequently washed with a 0.5% DIPEA/DMF (v/v) solution 
and a 0.5% dimethyldithiocarbamic acid sodium salt solution in DMF (w/v) to remove any palladium 
residues. Next, 1 equivalent of 1,1’-ferrocenedicarboxylic acid chloride and 10 equivalents of DIPEA in 
10mL of DMF were added to the resin under N2. The reaction was agitated for 24 hours to allow for 
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cyclization to occur. The resin was then treated with acetic anhydride in DMF to acylate any free amines 
which still may be present. The peptide was subsequently cleaved from the resin, and the solvent 
evaporated. The 
1
H NMR of the crude product (Figure 3.10) does not appear to contain peaks within the 
ferrocene region (4.50ppm-5.00ppm) which integrate proportionally.  
 
 
 
 
 
 
 
 
 
 
Figure 3.10: On resin cyclization of pentapeptide using dimedone as the scavenger 
Based on the rough integrations, it was assumed that no appreciable quantity of the desired cyclized 
product was synthesized and no purification attempts were made.  
It is of note that the source for this methodology was the first to mention the necessity of washing the 
resin with specific solutions post deprotection in order to remove any remaining palladium residues. 
Neither of the previous literature papers provided such details. Upon deeper investigation, it was 
discovered that all methodologies require special washes post deprotection. Given this, it is believed that 
the lack of removal of Pd(0) in previous attempts may have interfered with the cyclization process. Pd(0) 
is known to add to acid chorides, and as a result, excess catalyst may have been reacting with the 1,1’-
ferrocenedicarboxylic acid chloride during the subsequent step in synthesis.  
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3.9 Solution Phase Cyclization of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 
 
Due to the unsuccessful on-resin cyclization, a solution phase variant was attempted using Z protected 
lysine residues. First, the dried resin was added to the solid phase vessel and the resin was swelled with 
CH2Cl2 for 30 minutes with agitation. The Fmoc protecting group was then removed via a series of 
washes, followed by addition of the next amino acid dissolved in a minimal amount of DMF. The reaction 
was then gently agitated by shaking for one hour. The resin was then washed and the Fmoc group was 
once again removed, followed by subsequent addition of the next amino acid. This process could then be 
repeated as many times as necessary to complete synthesis of the desired peptide. In this manner, 
carboxybenzyl protected lysine, valine, alanine, and carboxybenzyl protected lysine were added to form 
the desired pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2. In order to remove the peptide from the 
solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours.  After 
rotary evaporation, the resulting peptide was triturated with diethyl ether to yield an off white solid.   
1D 
1
H NMR indicated that the desired product was present with little to no impurities. To confirm the 
peak assignments, a 2D 
1
H COSY was also taken and the exhibited cross peaks were consistent with the 
initial assignments from 1D 
1
H NMR. 
The product was then hydrogenated with 5% Pd on C under 40psi of H2 for 24 hours. The palladium 
catalyst was then filtered off through celite and cyclization with ferrocene was attempted. To a stirring 
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solution of the peptide under N2, 1 equivalent of 1,1’-ferrocenedicarboxylic acid chloride in 10mL of 
DMF was added dropwise over an hour. The final concentration of 1,1’-ferrocenedicarboxylic acid 
chloride in the solution was 0.75mM. The solution was allowed to stir for 24 hours and the solvent was 
subsequently removed using a rotary evaporator. The 
1
H NMR of the product indicates that ferrocene is 
present in the crude product mixture (Figure 3.11). 
 
Figure 3.11: Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 with ferrocene 
After evaporation the obtained black film was no longer soluble in MeOH. Due to time constraints, flash 
chromatography could not be fully completed, although intial TLC analysis indicated that pure MeOH 
was not a sufficient eluent. It is also noted that upon dissolution in DMF, the black film had a redish tint, 
possibly indicative of the presence of ferrocene. 
3.10 Summary and Conclusions 
The pentapeptides Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 was successfully synthesized using 
standard solid phase peptide synthesis techniques. While both solution and solid phase cyclization with 
1,1’-ferrocenedicarboxylic acid chloride was attempted, neither yielded the desired products in any 
recoverable quantity. Additionally, neither Aloc removal technique utilized for solution or solid phase 
52 
 
 
 
synthesis was fully successful. As such, it is evident that an alternative technique must be utilized for 
Aloc removal, or the current conditions must be refined for maximum efficiency.  
In addition, the pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 was successfully synthesized. Based 
on the 
1
H NMR spectrum, hydrogenation with 5% Pd on C under H2 only partially removed the Z 
protecting groups. It is believed, however, that the catalyst loading and reaction time can be optimized to 
ensure complete removal of the Z protecting groups. While full characterization of the product could not 
be completed due to time constraints, the 
1
H NMR spectrum appears to indicate the presence of ferrocene 
in the product. The best hypothesis based on the 1D 
1
H NMR integral values of the crude product, is that 
the product is mostly comprised of a single ferrocene coupled to two pentapeptides.  
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APPENDIX 
 
A.1 Synthesis of Boc-Cys(SCH2CCH)-OH 
Under an inert atmosphere of N2, 1.030g (0.044mol, 4.0 equiv) of sodium metal was dissolved in ~60mL 
of absolute ethanol. Once fully dissolved, 1.956g (0.0111mol, 1.0 equiv.) of L-cysteine hydrochloride 
hydrate and 4.90mL (0.044mol, 4.0 equiv.) of propargyl bromide was added to the solution and allowed 
to react for 2 hours. The ethanol was then evaporated off using a rotary-evaporator and the remaining 
product was redissolved in a minimal amount of THF. To the solution was then added 4.865g 
(0.0223mol, 2.0 equiv.) of Boc2O that was previously dissolved in approximately 12.5mL of THF. 
Additionally, 5.0mL (0.055mol, 5.0 equiv) of triethylamine and 25.0mL of deionized H2O was added to 
the flask and allowed to stir covered overnight with a syringe inserted into the rubber septum for gas 
change. The THF was then evaporated off and the solution was made basic through the addition of 1M 
NaOH. The aqueous layer was then washed with 3× ~25mL of ethyl acetate, acidified to a pH of 2 using 
concentrated HCl, and extracted using 3× ~25mL ethyl acetate. The remaining ethyl acetate layer was 
dried using MgSO4 and filtered into a round bottom flask (tare mass: 99.647g) and evaporated off using 
the rotary evaporator to yield a dark brown oil. The final mass of the flask was 101.606g (1.959g, 
0.0133mol product). The product was then confirmed using 
1
H
 
NMR and its purity was determined by 
TLC (Figure A1). The product had an Rf value of 0.67 with an eluent of 1:1 ethyl acetate:methanol.  
 
Figure A1: 
1
H NMR of Boc-Cys(Prg)-OH in CDCl3 
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1
H NMR: (CDCl3) δ 6.356ppm (1H, bs, OH), 5.392ppm (1H, d, 
3
J=7.66 Hz, NH), 4.617ppm (1 H, q, 
3
J=5.86, Cα-H), 3.3357ppm (2H, dd (qd), 2J=8.80Hz 3J=2.70Hz, CH2), 3.2687ppm (2 H, dd, 
2
J=13.27Hz 
3
J=4.84, CH2), 2.3155ppm (1 H, s, alkyne), 1.498ppm (9H, s, Boc-CH3).  
 
A.2 Synthesis of Boc-Cys(SCH2CCH)-Anisidine 
0.500g (0.00193mol) of previously synthesized Boc-Cys(SCH2CCH)-OH was dissolved in 2.07mL of 
CH2Cl2 to obtain a concentration of 0.9M. To the flask was then added 0.261g (0.00212mol, 1.1 equiv.) 
anisidine and the solution was allowed to stir in an ice water bath. Once the solution had reached 0°C 
(approximately 5 minutes) 0.443g (0.00231mol, 1.2 equiv.) of EDC was added and the solution was 
allowed to slowly warm to room temperature over a 4 hour period. The CH2Cl2 was evaporated off using 
a rotary evaporator and the remaining oil was redissolved in ethyl acetate and washed with 3×25mL of 
0.1M HCl, 3×25mL of saturated NaHCO3 solution, and 1×25mL brine, after which the ethyl acetate layer 
was dried with MgSO4 and the ethyl acetate was rotovapped off. The product was purified via flash 
chromatography (3cm diameter column, 2:1ethyl acetate/hexanes eluent) and massed at 80.116g (tare: 
79.858g). The structure was confirmed by 
1
H NMR and its purity was determined by TLC (Figure A2). 
The product had an Rf value of 0.57 with an eluent of 2:1 hexanes:ethyl acetate.  ESMS was also 
performed on the given sample, and the molecular ion peak, in addition several fragments were confirmed 
to be present. 
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Figure A2: 
1
H NMR of Boc-Cys(Prg)-Anisidine in CDCl3 
1
H NMR: (CDCl3) δ 8.1661ppm (1H, s, Ani-NH), 7.4289ppm (2 H, d, 
3
J=8.93Hz, Ani-CH), 6.8674ppm 
(2H, d, 
3
J=9.05, Ani-CH), 5.4372 (1H, d, 
3
J=6.64Hz, Cys-NH), 4.4887ppm (1 H, q, 
1J=6.76, CαH), 
3.7954ppm (3H, s, OMe), 3.343ppm (2 H, d, 
3
J=2.60, Prg-CH2), 3.1499ppm (2H, s (qd), 
2
J=52.21Hz,
 
3
J=14.02Hz, Cys-CH2),
 
2.3223ppm, 1H,  s, Alkyne-H), 1.4785ppm, 9H, s, Boc-(CH3)3). 
 
A.3 Synthesis of Boc-Cys(SCH2CCH)-OSu 
0.500g (0.00193mol) of Boc-Cys(SCH2CCH)-OH was dissolved in 4.00mL of CH2Cl2 and to this solution 
was added 1.56g (0.0145mol, 7.5 equiv.) of N-hydroxysuccinimide. The solution was then placed in an 
ice bath and allowed to cool to 0°C. Once at the desired temperature, 0.444g (0.00232mol, 1.2 equiv.) of 
EDC was added to the flask and the reaction was left for 4 hours while the solution slowly warmed to 
room temperature. An additional 15mL of CH2Cl2 was then added to the reaction flask and the solution 
was washed with 3× 25mL of 0.1HCl, 3×25mL of saturated NaHCO3 solution, and 1× 25mL brine. The 
CH2Cl2 layer was then dried using MgSO4, filtered, and evaporated using a rotary evaporator. The crude 
product was then purified using flash chromatography (3cm diameter column, 7:3 hexanes/ethyl acetate 
(350mL) and pure ethyl acetate eluents). The product was then massed at 45.198g (tare: 45.086g) and its 
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structure was confirmed by 
1
H NMR and its purity was determined by TLC (Figure A3). The desired 
product had an Rf value of 0.65 with an eluent of 2:1 ethyl acetate:hexanes.  
 
Figure A3: 
1
H NMR of Boc-Cys(Prg)-OSu in CDCl3 
 
1
H NMR: (CDCl3) δ 5.396ppm (1H, d, 
3
J=8.74Hz, Cys-NH), 4.9367ppm (1H, q, 
2
J=5.46Hz, 
3
J=6.92Hz, 
CαH), 3.3824ppm (2H, d, 3J=2.37Hz, Prg-CH2), 3.2248ppm (2H, s (qd), 
2
J=40.17 Hz, 14.40Hz, 
3
J=7.48, 
Cys-CH2), 2.8634ppm (4H, s, OSu), 2.3214ppm (1H, s, Alkyne-H), 1.4663ppm (9 H, s, Boc CH3)3). 
 
A.4 Synthesis of CF3CO2[Cys(SCH2CCH)-Anisidine] 
0.100g(0.000274mol) of Boc-Cys(SCH2CCH)-Anisidine was dissolved in ~1ml of CH2Cl2 and a single 
drop of anisole was added to the stirring solution. The reaction flask was placed in an ice bath and 
allowed to cool to 0°C. Once at the target temperature, 1mL of TFA was additionally added to the 
solution. The flask was slowly warmed to room temperature by the ambient room temperature (~4-
5hours) and the CH2Cl2 and TFA were stripped off using a high vacuum rotary evaporator. The grey-
yellow colored oil was left on the vacuum line overnight and massed the next day 37.832g (tare: 
37.709g).  
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A.5 Synthesis of Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine 
0.0726g(0.000274mol) of CF3CO2[Cys(SCH2CCH)-Anisidine] was first dissolved in a minimal amount 
of CH2Cl2 and a stir bar was added to the flask. To the stirring solution were then added 0.98g(1 equiv.) 
of Boc-Cys(SCH2CCH)-OSu and 0.29mL(7.6 equiv) of triethylamine in quick succession. The solution 
was allowed to react for 4 hours at room temperature and the CH2Cl2 was stripped off using a rotary 
evaporator. The golden yellow brown residue was then redissolved in ethyl acetate and transferred to a 
separatory funnel. The solution was washed with three times with 10mL of 0.1M HCl, three times with 
10mL of saturated NaHCO3 solution, and once with 10mL of brine. The ethyl acetate layer was then 
transferred into a round bottom flask and  the ethyl acetate was stripped from the solution and the flask 
was massed at 55.672g (tare: 55.630g), yielding a product mass of 0.042g. The product was then 
confirmed by both TLC and 
1
H NMR (Figure A4). The product was shown to be pure by TLC with an Rf 
of 0.60 in 3:2 ethyl acetate:hexanes. ESMS was also performed on the given sample, and the molecular 
ion peak, in addition several fragments were confirmed to be present.  
 
 Figure A4: 1H NMR of Boc-Cys(Prg)-Anisidine in CDCl3 
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1
H NMR: (CDCl3) δ 8.707ppm (1H, s, Ani-NH), 7.4502ppm (2H, d, 
2
J=35.1Hz, 
3
J=9.13, Ani-CH), 
6.1893ppm (2H, d, 
3
J=9.02Hz, Ani-H), 5.6185ppm (1H, d,  
3
J=6.37, Cys-NH), 5.523ppm (1H, d, 
2
J=99.54Hz, 
3
J=7.64, Cys-NH), 4.8748ppm (1H, q, 
2
J=5.94, 
2
J=5.94,  Cα), 4.4526ppm (1H, q, 2J=5.94, 
2
J=5.94,  Cα), 3.7697ppm (3H, s, OMe), 3.306ppm (4H, m, Cys-CH2), 3.119ppm (4H, m, Cys-CH2), 
2.332ppm (2H, m, Alkyne-H), 1.4418ppm (1H, s, Boc-(CH3)3).  
 
A.6 Synthesis of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine) 
Approximately 1500mL of methanol was first degassed using a partial vacuum and filtration flask. In the 
hood a 2L 3-neck Schlenk flask was set up within which 0.504g of W(dmtc)2(CO)3, which had been 
previously synthesized, was transferred. About 1.1L of the degassed methanol was then added to the 3-
neck reaction flask in addition to a stir bar. The stirring solution was then put under an inert atmosphere 
of N2 and stirred until most of the solid had dissolved. The solution was then brought to a gentle reflux 
using a heating mantle. Once at the moderate reflux, 0.504g of Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-
Anisidine, which had been dissolved in a 7mL of the degassed methanol, was added to the stirring 
solution using a 10mL syringe. Upon addition of the peptide, the solution immediately became a dark 
forest green color, indicating formation of the mono-alkyne complex. Reflux of the solution was 
continued until the solution had become a lemon yellow color, indicating that both alkynes had been 
coordinated, which took approximately 45 minutes to accomplish. The methanol was then stripped from 
solution. The product was then purified using flash chromatography and an eluent of 1:1 ethyl 
acetate:hexanes. Fractions 115-140 were then combined and transferred to a round bottom flask which 
was massed at 63.329g (tare: 62.291g), yielding a product mass of 0.408g. The desired product was then 
confirmed via 
1
H NMR, TLC, and ESI-MS (Figure A5, Figure A7). The desired product had an Rf value 
of 0.20 with an eluent of 1:1 ethyl acetate:hexanes. The purity of the product was also tested using HPLC 
(Figure A6). For HPLC analysis the gradient is provided in Table A1. Absorbance readings were all 
recorded at 310nm. 
Table A1: HPLC Gradient programming for Purity Analysis of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani 
Time 0.1% TFA Acetonitrile Flow 
0 80 20 1 ml/min 
6 50 50 1 
12 0 100 1 
20 0 100 1 
22 80 20 1 
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Figure A5: 
1
H NMR of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani)in CDCl3 
 
1
H NMR: (CDCl3) δ 11.3ppm (2H, s (m), Alkyne-H), 8.707ppm (1H, s, Ani-NH), 8.529ppm (1H, s, Gly-
NH), 7.5935ppm (2H, m, Ani-CH), 6.8515ppm (2H, m, Ani-CH), 5.324ppm (1H, m, Gly-NH), 
3.7997ppm (3H, m, OMe), 3.3137ppm (10H, m, DMTC + CH2), 3.127ppm (10H, m, DMTC + CH2),  
1.461ppm (9H, m, Boc-(CH3)3). 
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Figure A6: HPLC analysis of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani) 
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Figure A7: ESI-MS of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani) with theoretical mass and isotope pattern 
 
A.7 Variable Temperature studies of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine) 
A series of 1D 
1
H NMR spectrums with increasing sample temperatures was recorded. First, in order to 
avoid solvent evaporation effects during the heating process, the sample was dissolved in DMSO-d6. 
Next, an initial NMR was recorded at 293K, the normal temperature of the instrument. The probe was 
then heated to 300K and a second 
1
H NMR was recorded. 1D 
1H NMR’s were then taken at 320K, 330K, 
340K, 350K, 360K, and 364K, the maximum achievable temperature of the instrument. The sample was 
then allowed to cool down to its normal temperature (293K) and a final 
1
H NMR spectrum was recorded 
(Figure A8). 
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Figure A8: Vartaible Temperature 
1
H NMR of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani)in DMSO-d6 
 
 
The results of the VT-
1
H-NMR show near coalescence of the sample at 363K.  
 
A.8 DMSO titration of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine) 
In addition, a DMSO titration was performed in which 10mg of sample was dissolved in 75μL of CH2Cl2 
and the concentration of DMSO in the sample was increased in specific intervals. First, a 
1
H NMR
 
was 
recorded in pure CDCl3. Next, 8µL of DMSO-d6 was added to the sample and a 
1
H NMR was recorded. 
This was repeated 3 more times. This process was then repeated for two 16µL DMSO-d6 additions, one 
32µL addition and three 50μL additions. The chemical shifts of the two amide protons within the 
compound were then recorded for each of the 
1
H NMR spectrums taken (Figure A9, Table A2). The 
chemical shift was then plotted as a function of the DMSO-d6 concentration in the sample. When graphed 
the results of the DMSO titration clearly indicate that both amide protons in the coordinated peptide are 
involved in hydrogen bonds. 
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Figure A9: Chemical shift of selected NH peaks as a function of %DMSO of solvent  
Table A2: DMSO Titration data 
Solvent % DMSO Location of 1st NH peak Location of 2nd NH peak 
0 8.493 8.873 
0.096386 8.565 9.118 
0.175824 8.632 9.312 
0.242424 8.701 9.448 
0.299065 8.771 9.541 
0.390244 8.844 9.612 
0.460432 8.941 9.679 
0.571429 9.035 9.735 
0.666667 9.131 9.784 
0.727273 9.209 9.82 
0.769231 9.254 9.84 
 
 
 
 
 
 
8.4 
8.6 
8.8 
9 
9.2 
9.4 
9.6 
9.8 
10 
0 0.2 0.4 0.6 0.8 1 
C
h
e
m
ic
al
 S
h
if
t 
(p
p
m
) 
% DMSO 
Anisidine NH 
Internal Cys-NH 
64 
 
 
 
A.9 Synthesis of W(dmtc)2(Boc-Prg-Prg-OMe) 
A sample of Boc-Prg-Prg-OMe was first obtained from previous research and the structure of the sample 
was confirmed using 
1
H NMR (Figure A10).  
 
Figure A10: 
1
H NMR of Boc-Gly(Prg)-Gly(Prg)-OMe in CDCl3 
1
H NMR: (CDCl3) δ  7.169ppm (1H, s, Boc-Gly-NH), 5.386ppm (1H, s, Gly-NH), 4.673ppm (1H, s, Gly-
Cα), 4.311ppm (1H, s, Gly-Cα), 3.7234ppm (3H, s, OMe), 2.7144pp,-2.5665ppm (4H, s, Gly-Prg CH2), 
2.0523ppm (1H, s, Alkyne), 1.983ppm (1H, s, Alkyne), 1.3999 (9H, s, Boc-CH3) 
 
0.0915g (1 equiv) of the sample was then placed within a 3 neck 500mL round bottom flask, while 
300mL of methanol was degassed using a partial vacuum and a filter flask. Approximately 200mL of the 
degassed methanol and a stir bar were then transferred to the reaction vessel and the solution was put 
under an inert atmosphere of N2. The solution was then heated to a moderate reflux until most of the solid 
had dissolved. 0.055g (0.180mmol) of the Boc-Prg-Prg-OMe was then dissolved in a minimal amount of 
methanol and added into the stirring solution using a syringe. Upon addition of the peptide, the solution 
immediately became a dark forest green color, indicating formation of the mono-alkyne complex. Reflux 
of the solution was continued until the solution had become a lemon yellow color, indicating that both 
alkynes had been coordinated, which took approximately 2 hours to accomplish. The methanol was then 
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stripped from solution using a high vacuum rotary evaporator and the flask was massed at 131.260g (tare: 
131.121). The product was then redissolved in methylene chloride and methanol and flash 
chromatography was performed using a 2cm column and ethyl acetate as the eluent. Fractions 9-12 were 
pooled and confirmed to be the desired product through 
1
H NMR (Figure A11). The flask was massed at 
64.633g (tare: 64.553g). In addition a variable temperature NMR was conducted starting at 294K and 
increased at intervals of 10K to 344K, but no evidence of coalescence was noted.  
  
Figure A11: 
1
H NMR of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe in CDCl3 
1
H NMR: (CDCl3) δ 11.302ppm (2H, m, Alkyne-H),  5.369ppm (1H, s (d), 
3
J= 3.64Hz, Gly-NH), 
4.871ppm (1H, d, 
3
J=3.64Hz, Gly-NH), 4.55ppm (1H, s (q), Gly-Cα), 4.27ppm (1H, s (q), Gly-Cα), 
3.753ppm (3H, d (s), 
3
J=4.48Hz, OMe), 3.4017ppm (6H, s (dq), 
2
J=10.55, 
3
J=4.16Hz, dmtc), 3.0993ppm 
(6H, s (dq), 
2
J=10.55, 
3
J=6.80, dmtc), 1.3842ppm (9H, s, Boc-(CH3)3). 
 
A.10 Variable Temperature studies of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe  
A series of 1D 
1
H NMR spectrums with increasing sample temperatures was recorded. First, in order to 
avoid solvent evaporation effects during sample heating, the compound was dissolved in DMSO-d6. Next, 
an initial NMR was recorded at 293K, the normal temperature of the instrument. The probe was then 
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heated to 303K and a second 
1
H NMR was recorded. 1D 
1
H NMR spectrums were then taken at 313K, 
323K, 333K, and 343K. The sample was then allowed to cool down to its normal temperature (293K) and 
a final 
1
H NMR spectrum was recorded (Figure A12).  
 
Figure A12: Variable Temperature studies of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe in DMSO-d6  
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